You've got an investor meeting next week. The product works, customers are starting to pay, and someone has asked the awkward question: “What's the company worth?” So you open a spreadsheet, build a beautiful forecast, and land on a number that feels both exciting and faintly ridiculous.
That feeling is usually right. Company valuation methods aren't equally useful at every stage. A DCF can look impressive while telling a pre-seed founder very little. A simple comparable transaction can be rough around the edges, yet hold up better in a Series A negotiation. In New Zealand and Australia, the method has to fit the company, the market, and the purpose of the valuation.
Valuation isn't a hidden truth waiting to be discovered. It's a stage-specific negotiating tool. The number helps founders price a fundraise, test an acquisition offer, set an option price, or explain value to a board. Change the purpose, and the useful method may change too.
New Zealand practice groups valuation into three foundation approaches, asset, income, and market, with practical methods such as net asset backing, discounted cash flow, capitalisation of earnings, and industry-specific techniques outlined in this NZ business valuation guide. The right starting point depends on whether value sits mainly in physical assets, current earnings, or future cash flow potential.
An asset-based approach asks what remains after valuing assets and subtracting liabilities. It makes sense for a property-holding company, a manufacturer with valuable equipment, or a distressed business being considered on a break-up basis. It's usually a poor lead method for a SaaS company whose most valuable assets are code, customer relationships, and a hard-won distribution channel.
An income-based approach values future economic benefits. DCF belongs here, as does capitalisation of maintainable earnings. An established software company with reliable forecasts can make a strong case with this approach. A pre-revenue founder with a five-year spreadsheet and no paying customers cannot. The maths may be correct, but the assumptions carry the entire load.
A market-based approach compares the company with relevant public companies or private transactions. Local valuation guidance describes market techniques that include direct market data, guideline public companies, dividend-paying capacity, and previous sales of interests in the company in this New Zealand methods overview. For a young SaaS business, this often gives investors a more familiar reference point than a heroic forecast.
Suppose a Wellington SaaS founder builds a DCF and gets an implied value of NZD 4 million. That number might look polished, but an Auckland angel will ask whether the company has enough evidence to support the forecast. If the answer is no, the model becomes a negotiation liability. The founder may issue a SAFE at an inflated cap, then face a sharp repricing when later investors use actual revenue and local comparables.
Under NZ IFRS 13, fair value is the price received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. In plain English, it's an exit price today, not the price you hope the company will command after a future round under the standard's fair value definition.
Practical rule: At pre-seed, triangulate a credible range. Don't fall in love with a single spreadsheet output.
DCF works best when a company can defend its forecast. It asks a simple question: what are the company's future free cash flows worth today, after allowing for risk and the time value of money?
Use the core formula:
Present value = Future free cash flow ÷ (1 + discount rate)ⁿ
Take a fictional Wellington SaaS business, Beacon CRM. Its finance lead prepares a five-year forecast, estimates free cash flow after operating costs and investment, then applies a discount rate built from a current risk-free reference and a justified technology risk premium. A New Zealand valuation guide cites a long-term nominal forward rate of about 4.8% in early 2026, which shows why the rate needs a current source rather than a stale assumption in its discussion of NZ technology valuations.
The table below is an illustrative model, not a market claim. The figures are fictional and show the structure of a DCF rather than a forecast for Beacon CRM.
| Year | Revenue (NZD) | FCF (NZD) | Discount Factor | Present Value |
|---|---|---|---|---|
| 1 | 500,000 | 50,000 | 0.83 | 41,500 |
| 2 | 800,000 | 120,000 | 0.69 | 82,800 |
| 3 | 1,200,000 | 240,000 | 0.57 | 136,800 |
| 4 | 1,700,000 | 390,000 | 0.47 | 183,300 |
| 5 | 2,300,000 | 575,000 | 0.39 | 224,250 |
The terminal value often dominates a technology DCF. That makes sense mathematically, because the model assigns value to cash flows beyond the explicit forecast period. It also creates false confidence if the terminal growth rate or multiple has no support.
Skip DCF as the primary answer when the company is pre-revenue, revenue is swinging sharply, or management can't explain the path from current activity to future cash. Use it as a thinking tool, not a magic verdict. At Series A, it becomes more useful when forecasts have operating evidence behind them, but still needs a market-based cross-check.
Present the model to investors as a range with clear sensitivities. A good founder says which assumptions matter, what would break them, and how the result compares with local evidence. That earns more trust than pretending the output is precise to the last dollar.
Multiples are fast, familiar, and easy to misuse. For New Zealand SMEs, earnings multiples commonly sit in a 1x to 5x range, so the core work lies in selecting and normalising maintainable earnings before applying the multiple as set out in this NZ multiples fact sheet. Remove one-off revenue, abnormal expenses, and owner perks first. Otherwise, the multiple is being applied to fiction.
For SaaS, founders often reach for revenue or ARR because current earnings are suppressed by product and sales investment. That can be sensible, but revenue alone hides too much. Two businesses with the same ARR may have very different gross margins, churn, customer concentration, sales efficiency, and retention. A business with weak margins shouldn't borrow the multiple of a cleaner, more durable subscription company.
Use EV/ARR when recurring revenue is recurring and the data is clean. Use EV/EBITDA when the company has stable profitability. Use revenue multiples as a supporting lens when growth is strong but earnings are still being reinvested. For SaaS, the Rule of 40 can help frame the relationship between growth and profitability, but it shouldn't replace judgement.
For practical comparable-company work, review TIN200, NZX-listed technology companies, ASX small-cap technology filings, and paid databases such as Mergermarket or PitchBook with ANZ filters where access is available. Public companies need size and liquidity adjustments. Private deals need adjustments for deal terms, control, and the quality of the disclosed numbers.
A useful guide to the mechanics is Bizbe, Inc.’s resource on comparing FedEx route valuations. The subject matter differs from SaaS, but the lesson travels well: comparable analysis only works when you explain why the comparison is comparable.
The table below is fictional. It demonstrates the fields a founder should collect, not actual transaction evidence.
| Comparable Company | ARR (NZD) | YoY Growth | Gross Margin | EV/ARR Multiple |
|---|---|---|---|---|
| Comparable A | 1,500,000 | 35% | 78% | 4.0x |
| Comparable B | 3,000,000 | 20% | 66% | 2.8x |
| Subject company | 2,000,000 | 28% | 70% | To assess |
A NZD 2 million ARR company shouldn't average the two multiples. It might deserve a result between them, but the founder must document why. Size, growth, margin, customer concentration, and market liquidity all matter. A useful comparison is a bridge from the comparable to the subject company, not a number lifted from a slide deck.
Pre-seed valuation is part finance, part judgement, and part negotiation. There's usually too little revenue for a reliable earnings multiple, and too much uncertainty for a serious DCF. Investors want a structured view of risk, while founders want recognition for the work already done.
Four approaches show up often:
The worked figures should remain illustrative. A pre-seed company with no revenue might produce a lower range under a cautious Scorecard, a broader range under Berkus, and a very different answer under the VC Method. That difference isn't a flaw. It tells you the company needs a triangulated range rather than false precision.
| Method | Best Stage | Key Inputs | Typical NZD Range |
|---|---|---|---|
| Berkus | Pre-seed | Product, team, relationships, early validation | Illustrative range only |
| Scorecard | Pre-seed to seed | Local peer comparison and risk weights | Illustrative range only |
| VC Method | Seed | Exit value, return requirement, dilution | Illustrative range only |
| Risk-factor summation | Pre-seed | Named risks and adjustment factors | Illustrative range only |
Local angels may accept a Berkus or Scorecard framework on a term sheet because it gives both sides a common language. They'll still push back if the founder treats the result as a certified market value. NZGCP-linked syndicates and experienced investors usually care more about the evidence behind the assumptions than the label on the method.
Founders validating their customer problem should also keep the commercial evidence organised, not tucked away in a founder's notebook. This guide on how to validate a startup idea is a useful companion before assigning too much value to a polished prototype.
Precedent transactions are often more useful than founders expect, provided they accept the limitations. The method asks what buyers or investors paid for similar businesses, then adjusts for differences. In New Zealand, the main issue isn't a lack of intelligence. It's a small sample of disclosed deals.
Start with three transactions that resemble the subject company in product, revenue quality, customer base, growth profile, and geography. Record the enterprise value, ARR or revenue, deal structure, and date. Then calculate the implied multiple. Don't mix a full acquisition with a small minority investment without explaining the difference.
Suppose a NZ SaaS founder is assessing a potential sale. The founder finds three relevant transactions through public disclosures, portfolio materials, and adviser conversations. One deal has stronger growth, another has better margins, and the third is older. The median implied EV/ARR multiple may provide a starting point, but it isn't the answer.
Apply adjustments for:
Useful local places to look include Icehouse Ventures portfolio reports, Punakaiki Fund disclosures, NZ Private Equity Association deal lists, and ASX small-cap technology filings. Mergermarket and PitchBook can add depth when the budget allows, but paid access doesn't fix a poor comparable set.
The table below uses fictional transactions to show a clean working format. It isn't evidence of actual NZ deals.
| Comparable Deal | Deal Size (NZD) | EV/ARR Multiple | Adjustment Notes |
|---|---|---|---|
| Harbour Workflow | 1,200,000 | 2.5x | Smaller customer base, steadier growth |
| Southern Field App | 3,500,000 | 3.2x | Stronger retention, larger buyer |
| Tasman Billing SaaS | 6,000,000 | 4.0x | Higher growth, broader distribution |
When the sample is small, show all three transactions and explain the adjustments. Hiding the messy deal makes the valuation look tidy, but it also makes it easier for an investor or buyer to pull apart.
The right method depends on what you're trying to do. A founder raising a first round needs a negotiable range. A founder selling the company needs evidence of what a buyer could pay. An employee option price needs a defensible fair-value process, not a fundraising headline.
| Stage or goal | Primary method | Secondary check |
|---|---|---|
| Pre-seed | Berkus, Scorecard, or founder assessment | Local precedent transactions |
| Seed | Scorecard or VC Method | Revenue evidence and transaction data |
| Series A | DCF with tested assumptions | Comparable companies and transactions |
| Growth | DCF, earnings, or LBO analysis | Precedent transactions |
| M&A | Precedent transactions | DCF and market comparables |
| ESOP or option pricing | Fair-value analysis | Market and income approaches |
At pre-seed, stop obsessing over a single number. At Series A, DCF can carry more weight when you have three or more years of forecasts you trust, but comparables should dominate the conversation because investors price risk against available market evidence. At growth stage, a buyer may use DCF, an LBO model, and precedent transactions together.
NZ IFRS 13 matters when the purpose calls for fair value. Its exit-price framing asks what market participants would pay at the measurement date, rather than what the founder believes the business might be worth after a perfect execution year. That distinction becomes important for investor reporting, option work, and sale preparation.
A secondary sale needs its own lens. The holder may be selling a minority interest with limited control, while a strategic buyer may pay for synergies. A clear framework for how to determine acquisition fit helps separate the company's standalone value from the value to one particular buyer.
Founders should also distinguish the company from the structure around it. A practical guide to sole trader versus company in NZ helps clarify why ownership, liability, and tax structure can affect the valuation conversation, even though the operating business remains the central subject.
The most expensive mistake is importing a US multiple without importing the US company's scale, margins, retention, market access, and liquidity. A founder with NZD 400,000 ARR who applies a 12x ARR multiple from a Silicon Valley scale-up has made a category error. The resulting SAFE may look generous, but later investors can force a reset when the company's local evidence doesn't support it.
Top-line revenue also gets too much credit. Revenue can include project work, discounts, implementation fees, or a large customer that may leave. Buyers care about the durability and profitability of revenue, not merely its size.
| Mistake | Typical impact | Fix |
|---|---|---|
| US comps used without adjustment | Inflated expectations and difficult later rounds | Use NZ and AU evidence, then document scale and liquidity adjustments |
| Top-line treated as value | Ignores margin, churn, concentration, and revenue quality | Analyse maintainable earnings, ARR quality, and customer mix |
| IFRS 13 exit price ignored | Founder hopes replace current market evidence | Anchor the analysis to an orderly transaction at the measurement date |
| Inflated SAFE valuation cap | Later dilution can surprise founders and early investors | Model conversion across downside and base cases |
| Primary capital priced too highly | The company gives up too little equity for a difficult price | Compare the proposed terms with local transaction evidence |
| Equity and options mixed up | ESOP expectations become unclear | Separate issued shares, options, and reserved pool capacity |
| No downside scenario | The board has no plan if growth slows | Stress-test the model and define cash actions |
An overvalued pre-seed round can scar the cap table for years. The founder may need to raise at a lower price later, accept punitive terms, or spend precious time defending a number no longer supported by performance.
The fix is not another elaborate spreadsheet. Stress-test the multiple against local precedent transactions, write the assumptions in a valuation memo, and get independent advice before a major round. For a NZ-registered company, the fair-value question remains practical: what would a willing market participant pay now?
Before opening the data room, run four checks. They're boring in the best possible way. Clean inputs and clear assumptions save more time than a clever valuation trick.
Reconcile revenue, gross margin, retention, burn, IP ownership, and the cap table. Keep the financial statements consistent with the operating metrics. A financial review should also cover contracts, liabilities, payroll, tax, and working capital. This financial due diligence checklist is a useful prompt for the wider data room.
Gather relevant NZ and AU transactions, review current comparable-company evidence, and note changes in the funding environment. Don't use an old deal because it produces a flattering answer.
Source the discount rate from a current NZ or AU risk-free reference and add a justified risk premium. Tie growth assumptions to cohort evidence, sales capacity, and retention. Test terminal assumptions at plus or minus two percentage points, then document the effect.
The rule is simple: stage dictates the weighting, not personal preference. Use Berkus and Scorecard at pre-seed, DCF and multiples from Series A onward, and precedent transactions for M&A. Cross-check at least two methods, record why each received its weight, and use an independent NZ-registered valuer before a round above NZD 2 million.
Valuation is a range, not a single number. Defending the range matters more than defending the midpoint.
NZ Apps helps NZ and Australian founders research the local app and tech company ecosystem, with practical guides and a curated directory for operators, investors, and buyers. Visit NZ Apps to find regional market resources and strengthen the evidence behind your next valuation conversation.
Add your NZ or Australian app or tech company to the NZ Apps directory and get discovered by founders and operators across the region.
Get ListedReach tech decision-makers across New Zealand and Australia. Sponsored and dofollow editorial links, permanent featured listings, and sponsored articles on a DA30+ .co.nz domain.
See Options